Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7616
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:15
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Zhangzhou Pientzehuang Pharmaceutical Co Ltd (Pientzehuang), a subsidiary of Zhangzhou Jiulongjiang Construction Co Ltd, is a pharmaceutical company that manufactures and markets traditional Chinese medicines. The company develops medicines and health products, cosmetics, daily chemicals, medical apparatus and instruments, and health food. Its products include pien tze huang capsules, chuangbei qingfei syrup, zengru gao, huoxiang zhengqi shui, xinshubao tablet, qingre zhikegranule, jintangning capsule, niuhuang jiedu tablet, liuwei dihuang pills, zhibai dihuang pills, qiju di huang pills, hugan tablet and danshen tablet compounds, and others. Pientzehuang develops its products through its research workstations. The company sells its products through a network of distributors in China, Thailand, Malaysia, Japan, Indonesia, Hong Kong and Canada. Pientzehuang is headquartered in Zhangzhou, China.

Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Zhangzhou Pientzehuang Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhangzhou Pientzehuang Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Zhangzhou Pientzehuang Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zhangzhou Pientzehuang Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Zhangzhou Pientzehuang Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 9
Partnerships 9
Zhangzhou Pientzehuang Pharma to Form Joint Venture with China Based Pharma Company 9
Shanghai Jahwa to Form Joint Venture with Zhangzhou Pientzehuang Pharma 10
Zhangzhou Pientzehuang To Form Joint Venture With China Resources Medications 11
Zhangzhou Pientzehuang Pharmaceutical Co Ltd – Key Competitors 12
Zhangzhou Pientzehuang Pharmaceutical Co Ltd – Key Employees 13
Zhangzhou Pientzehuang Pharmaceutical Co Ltd – Locations And Subsidiaries 14
Head Office 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List of Tables
Zhangzhou Pientzehuang Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Zhangzhou Pientzehuang Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Zhangzhou Pientzehuang Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhangzhou Pientzehuang Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Zhangzhou Pientzehuang Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zhangzhou Pientzehuang Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Zhangzhou Pientzehuang Pharma to Form Joint Venture with China Based Pharma Company 9
Shanghai Jahwa to Form Joint Venture with Zhangzhou Pientzehuang Pharma 10
Zhangzhou Pientzehuang To Form Joint Venture With China Resources Medications 11
Zhangzhou Pientzehuang Pharmaceutical Co Ltd, Key Competitors 12
Zhangzhou Pientzehuang Pharmaceutical Co Ltd, Key Employees 13

List of Figures
Zhangzhou Pientzehuang Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Zhangzhou Pientzehuang Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Zhangzhou Pientzehuang Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Zhangzhou Pientzehuang Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhangzhou Pientzehuang Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Zhangzhou Pientzehuang Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fox Corp (FOXA):企業の財務・戦略的SWOT分析
    Fox Corp (FOXA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Itausa – Investimentos Itau SA (ITSA4):企業の財務・戦略的SWOT分析
    Itausa - Investimentos Itau SA (ITSA4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Chesapeake Lodging Trust:企業のM&A・事業提携・投資動向
    Chesapeake Lodging Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Chesapeake Lodging Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Dampier Gold Limited:企業の戦略・SWOT・財務分析
    Dampier Gold Limited - Strategy, SWOT and Corporate Finance Report Summary Dampier Gold Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Vifor Pharma AG-製薬・医療分野:企業M&A・提携分析
    Summary Vifor Pharma AG (Vifor Pharma), a subsidiary of Galenica Ltd is a healthcare service provider that discovers, develops, manufactures, and commercializes prescription and over the counter pharmaceutical products for the treatment of iron replacement therapy. The company offers products for tr …
  • Endress+Hauser AG:企業の戦略的SWOT分析
    Endress+Hauser AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Megapharm Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Megapharm Ltd (Megapharm) is a biotechnology company that offers marketing of pharmaceutical products for international companies. The company markets products in therapeutic areas such as central nervous system, dermatology, gastroenterology, urology, respiratory and allergy, oncology, rheu …
  • 8point3 Energy Partners LP (CAFD):電力:M&Aディール及び事業提携情報
    Summary 8point3 Energy Partners LP (8point3 Energy) is a renewable energy company that owns, operates and acquires solar energy generation projects. The company offers operation and maintenance, project development, and technical services. It operates residential, commercial, industrial, and utility …
  • Aegis Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Aegis Therapeutics LLC (Aegis Therapeutics) is a drug-delivery and drug-formulation technologies company that commercializes drug delivery and protein stabilization technologies through product specific licenses to pharmaceutical and biopharmaceutical companies. The company offers Intravail, …
  • BrainCool AB (BRAIN):企業の製品パイプライン分析2018
    Summary BrainCool AB (BrainCool), a subsidiary of Dignitana AB, is a medical device company that focuses on developing, and commercializing medical cooling systems for brain cooling and pain management. The company’s products are based on the principle that applying therapeutic hypothermia contribut …
  • Enel SpA (ENEL):企業の財務・戦略的SWOT分析
    Enel SpA (ENEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Atopix Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Atopix Therapeutics Ltd (Atopix) is a clinical stage biotechnology company that develops novel treatments for Th2-mediated eosinophilic asthma. The company’s product portfolio includes CRTH2 used in the treatment of atopic dermatitis. It also offers ATX2417 and OC459 used in treatment of ast …
  • Keio University:製薬・医療:M&Aディール及び事業提携情報
    Summary Keio University (Keio) is an educational institution that offers education and research services. The institute provides primary and secondary education, graduate and undergraduate courses, and information technology courses. It offers academic courses in the fields of law and economics, hum …
  • Luminex Corp (LMNX):企業の財務・戦略的SWOT分析
    Luminex Corp (LMNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Fluor Corp (FLR):企業の財務・戦略的SWOT分析
    Fluor Corp (FLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Chagala Group Limited:企業の戦略・SWOT・財務情報
    Chagala Group Limited - Strategy, SWOT and Corporate Finance Report Summary Chagala Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • FirstRand Limited (FSR):企業の財務・戦略的SWOT分析
    FirstRand Limited (FSR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Blue Energy Ltd (BUL):企業の財務・戦略的SWOT分析
    Summary Blue Energy Ltd (BEL) is an oil and gas company that provides exploration and development services. The company provides exploration and production of coal seam gas and conventional oil, and gas resources in Australia. Its projects portfolio includes Carpentaria basin, Bowen basin, galilee b …
  • Obalon Therapeutics Inc (OBLN):製薬・医療:M&Aディール及び事業提携情報
    Summary Obalon Therapeutics Inc (Obalon Therapeutics) is a manufacturer of medical devices and equipment. The company offers development and commercializing medical devices to treat obese and overweight people by facilitating weight loss. It also researches, designs, produces, and sells medical gast …
  • Applied Industrial Technologies, Inc.:企業の戦略・SWOT・財務情報
    Applied Industrial Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Applied Industrial Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆